Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 27, 2025 09:01 ET | Source: Research and Markets

DLL3-Targeted Immunotherapy Competitor Analysis Report 2025: The Field Still is in Mid-stage Clinical Development Without Clear Leader in the Competition

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "DLL3-Targeted Immunotherapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering.This competitive intelligence report...
November 17, 2025 08:30 ET | Source: SNS Insider pvt ltd

Somatostatin Analogs Market Size to Reach USD 14.32 Billion by 2032 as Advanced Treatments Accelerate Global Adoption | SNS Insider

Austin, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Somatostatin Analogs Market Size and Growth Analysis: According to SNS Insider, the Somatostatin Analogs Market was valued at USD 5.25 billion in 2024 and...
October 22, 2025 10:28 ET | Source: Research and Markets

Neuroendocrine Tumors Pipeline Research Report 2025: Growth Prospects in Clinical Advancements, Collaborative Efforts, and Unmet Therapeutic Needs

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The "Neuroendocrine Tumors - Pipeline Insight,...
October 20, 2025 10:31 ET | Source: Research and Markets

Targeted Alpha Therapies for Cancer Treatment Research Report 2025: Advances in Drug Delivery Strategies, Theranostics, Pipeline Analysis, Key Takeaways - Global Market Forecast to 2030

Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapies for Cancer Treatment: Global Market" report has been added to ResearchAndMarkets.com's offering.The report provides an...
October 06, 2025 05:38 ET | Source: Research and Markets

Gastroenteropancreatic Neuroendocrine Tumors Market Analysis and Forecast Report 2025-2035 | Innovative Therapies Redefine Treatment Landscape for Rare GEP-NETs

Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The "Gastroenteropancreatic Neuroendocrine Tumors Market - A Global and Regional Analysis: Focus on Drug Class, Route of Administration, and Region -...
May 22, 2025 07:53 ET | Source: Research and Markets

Targeted Alpha Therapy Market Research 2024-2028: Drugs Approval, Proprietary Technologies & Clinical Trials Insights - Xofigo Sets Global Standard for Advanced Prostate Cancer Treatment

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" has been added to ...
May 22, 2025 07:37 ET | Source: Research and Markets

Peptide Cancer Drug Clinical Trials Market Insights, 2030: Multi-functional Peptides - A New Frontier in Theranostics

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030" has been added to ResearchAndMarkets.com's offering. ...
April 21, 2025 06:49 ET | Source: Research and Markets

Gastric Neuroendocrine Tumors Market Report 2025 | Advancements in Diagnostics Propel Early Detection of gNETs

Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Gastric Neuroendocrine Tumors Market" report has been added to ResearchAndMarkets.com's offering. The gastric neuroendocrine tumor (gNET) market,...
December 16, 2024 10:53 ET | Source: Research and Markets

Targeted Alpha Therapy Market, Drugs Approval, Proprietary Technologies & Clinical Trials: 20+ Drugs of Targeted Alpha Therapy In Clinical Trials

Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Targeted Alpha Therapy Market Size, Drugs Approval, Proprietary Technologies & Clinical Trials Insight 2028" report has been added to ...
November 27, 2024 04:10 ET | Source: Research and Markets

Peptide Cancer Drug Market Research 2024-2030: 230 Drugs in Clinical Trials, 30 Approved Drugs, $18 Billion Opportunity, Commercially Approved Peptide Cancer By Brand Name, Company and Indication

Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...